Literature DB >> 3890446

Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome.

J H Saurat.   

Abstract

Eczema is one of the cutaneous manifestations of primary immune deficiencies. It may therefore serve as a model for the understanding of atopic dermatitis (AD) provided the eczema in the immune deficiency under consideration is a constant feature and is similar to AD. In the Wiskott-Aldrich syndrome the eczematous eruption is (i) a constant feature of the syndrome, (ii) indistinguishable from AD when diagnostic criteria for AD are used, and (iii) clears dramatically after a successful bone marrow graft, which suggests that immune dysfunction is directly involved in the pathogenesis of the eczema.

Entities:  

Mesh:

Year:  1985        PMID: 3890446

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  6 in total

Review 1.  Immunopathology of atopic dermatitis.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1992

2.  The Natural Course of Atopic Dermatitis and the Association with Asthma.

Authors:  Min Qiao; Deqi Xiao; Li Qian; Jian'ou Qiao
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

3.  Death from eczema herpeticum in a child with severe eczema, mental retardation and cataracts.

Authors:  C I Ewing; H P Roper; T J David; M R Haeney
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

Review 4.  Pharmacophysiology of atopic dermatitis.

Authors:  J M Hanifin
Journal:  Clin Rev Allergy       Date:  1986-02

5.  Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.

Authors:  K H Hsieh; M F Shaio; T N Liao
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

Review 6.  The relationship between HIV infection and atopic dermatitis.

Authors:  Donald Rudikoff
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.